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Background: Substantial data indicate potential health consequences of untreated postpartum depression (PPD)
on the mother, infant, and family. Studies have evaluated interpersonal psychotherapy (IPT) as treatment for PPD;
however, the results are questionable due to methodological limitations. A comprehensive review of maternal
treatment preferences suggests that mothers favor ‘talking therapy’ as a form of PPD treatment. Unfortunately, IPT is
not widely available, especially in rural and remote areas. To improve access to care, telepsychiatry has been
introduced, including the provision of therapy via the telephone.
Methods/Design: The purpose of this randomized controlled trial is to evaluate the effect of telephone-based IPT
on the treatment of PPD. Stratification is based on self-reported history of depression and province. The target
sample is 240 women. Currently, women from across Canada between 2 and 24 weeks postpartum are able to
either self-identify as depressed and refer themselves to the trial or they may be referred by a health professional
based on a score >12 on the Edinburgh Postnatal Depression Scale (EPDS). Following contact by the trial
coordinator, a detailed study explanation is provided. Women who fulfill the eligibility criteria (including a positive
diagnostic assessment for major depression) and consent to participate are randomized to either the control group
(standard postpartum care) or intervention group (standard postpartum care plus 12 telephone-based IPT sessions
within 12 to 16 weeks, provided by trained nurses). Blinded research nurses telephone participants at 12, 24, and
36 weeks post-randomization to assess for PPD and other outcomes including depressive symptomatology, anxiety,
couple adjustment, attachment, and health service utilization. Results from this ongoing trial will: (1) develop the
body of knowledge concerning the effect of telephone-based IPT as a treatment option for PPD; (2) advance our
understanding of training nurses to deliver IPT; (3) provide an economic evaluation of an IPT intervention; (4)
investigate the utility of the EPDS in general clinical practice to identify depressed mothers; and (5) present valuable
information regarding PPD, along with associated couple adjustment, co-morbid anxiety and self-reported
attachment among a mixed rural and urban Canadian population.
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Postpartum mood disorders are the most frequent form of
maternal morbidity following childbirth [1]. These
affective disorders range in severity from the early mater-
nity blues to postpartum psychosis, a serious state affect-
ing <1 % of mothers [2]. Within this group of disorders is
postpartum depression (PPD), a condition often exhibiting
the disabling symptoms of dysphoria, tearfulness, sleep
difficulties, changes in appetite, guilt, anergia, problems
with concentration, and suicidal ideation. Frequently ex-
acerbating these indicators are low self-esteem, inability to
cope, feelings of incompetence, and loneliness [3-6]. The
onset rate of PPD is greatest in the first 12 weeks postpar-
tum [7], with duration frequently dependent on severity
[8] and time to onset of treatment [9]. While residual
symptoms are common [10], 50 % of mothers will remain
clinically depressed at 6 months postpartum [11,12], with
an estimated 25 % of untreated PPD continuing past the
first year [13].
PPD is a major health problem for many women from
diverse cultures [14]. Longitudinal and epidemiological
studies have yielded varying prevalence rates, ranging
from 3 % to >25 % of women in the first year following
delivery; these rates fluctuate due to sampling, timing of
assessment, differing diagnostic criteria (major or minor
depression), use of self-report measures, and whether the
studies were retrospective (low rates) or prospective (6- to
10-fold higher). A meta-analysis of 59 studies reported an
overall prevalence of major PPD to be 13 % [15]; it is note-
worthy that the absolute difference in estimates between
self-report assessments and diagnostic interviews was
small, and rates did not differ between primiparous and
multiparous mothers [15-17]. While the cause of PPD
remains unclear [10], extensive research suggests a
multifactorial etiology. Epidemiological studies and meta-
analyses of predictive studies have consistently implied the
importance of psychosocial variables [10,15,16], especially
marital conflict [15,16,18-20] and a lack of social support
[4,5,7,15,16,19,21].
PPD has well-documented health consequences for the
mother, child, and family. While women who have suffered
from PPD are twice as likely to experience future episodes
of depression over a 5-year period [22], infants and children
are particularly vulnerable. PPD can cause impaired mater-
nal-infant interactions [23] and negative perceptions of in-
fant behavior [24], which have been linked to childhood
attachment insecurity [25,26], emotional developmental
delay [25,27], and social/interaction difficulties [28,29].
Infants as young as 3 months of age are able to detect their
mothers’ mood and to modify their own responses accord-
ingly [30]. While cognitive skills [31], expressive language
development [32], and attention [33] have been negatively
influenced by PPD, children of depressed mothers are 2 to
5 times more likely to develop long-term behavioralproblems [34,35]. Child neglect/abuse [36] and marital
stress resulting in separation or divorce [37,38] are other
reported outcomes. Maternal and infant mortality are rare
but real consequences of PPD. Effective treatment of PPD
is needed to not only help the mother but also to prevent
these aforementioned consequences.
Antidepressant medication, cognitive behavioral therapy,
and interpersonal psychotherapy (IPT) have been validated
as effective treatments for general depression [39]. How-
ever, mothers are often reluctant to take antidepressants
due to concerns about breast milk transmission or potential
side effects [4]. Although there is evidence that antidepres-
sants are relatively safe for breastfed infants, the American
Academy of Pediatrics [40] classifies most antidepressants
as ‘drugs whose effect on nursing infants is unknown but
may be of concern’. Furthermore, recent studies have
demonstrated several potential sequelae including cardio-
vascular malformations which have fueled the debate about
the safety of antidepressants in the perinatal period [41,42].
Given these considerations, it is important that non-
pharmacologic interventions be evaluated for use with post-
partum women.
Dennis’ review of non-pharmacologic treatments [43]
suggests that while psychosocial and psychological inter-
ventions may be beneficial, many studies have serious
methodological limitations such as small sample sizes,
non-random group allocation, or a lack of a control
group. Thus, there remains a need for rigorous research to
evaluate well-defined interventions for the treatment of
PPD. To understand maternal treatment preferences for
PPD, Dennis completed a qualitative systematic review
[44]. For many mothers, the most desired treatment option
was the opportunity to talk about their feelings [45-50]. In
particular, the provision of ‘talking therapies’ with a health
professional was universally expressed as the main treat-
ment preference in a cross-cultural study incorporating 11
countries [51]. Maternal acceptance of treatment strategies
is important due to its direct impact on intervention en-
gagement and compliance [52,53]. Based on: (1) two meta-
analyses suggesting that a lack of social support and marital
conflict are consistent PPD risk factors [15,16], (2) maternal
treatment preferences related to ‘talking therapies’ [51], (3)
demonstrated effectiveness among depressed postpartum
and non-postpartum samples [54-57], the evidence points
to interpersonal psychotherapy (IPT) as a potentially effect-
ive treatment for mothers experiencing PPD.
IPT is a manual-based, time-limited psychotherapeutic
approach with a basic premise that depression, regardless
of etiology, is initiated and maintained within an interper-
sonal context. The goal of IPT is to achieve symptomatic
relief for depression by addressing current interpersonal
issues related to universal experiences of losses, changes, or
conflicts associated with its onset or perpetuation; IPT does
not seek to attribute interpersonal problems to underlying
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is primarily concerned with interpersonal functioning and
symptoms, presumed to have biological, psychological, and
social precipitants. There is a specific focus on social inter-
actions, communication, social supports, and interper-
sonal functioning [58].
IPT is supported by principles of classic and con-
temporary interpersonal theories, including the works
of Meyer, Sullivan, and Bowlby. Meyer conceptualized
the bio-psycho-social formulation of illness [56]. Sulli-
van was among the first psychoanalysts to focus on
interpersonal, rather than intrapsychic aspects of ex-
perience [59], and Bowlby was the father of attach-
ment theory [60]. Attachment theorists view
relationships as critical for survival and optimal func-
tioning. When attachment relationships are ruptured,
lost, or disordered, psychopathology can emerge, often
in the form of depressive symptomatology and mal-
adaptive interpersonal function. IPT can be seen as
indirectly addressing these issues within the thera-
peutic frame [61]. IPT is also founded on empirical
data based on the work by Brown and Harris on in-
timacy and social support [62,63], Pearlin and Lieber-
man on stressors including depression [64], and
Weissman on the role of marital disputes in depres-
sion [65-67]. IPT sessions focus on examining the
person’s interpersonal relationships, linking them to
changes in mood, identifying a major problem area
(that is, grief, interpersonal role disputes, role transi-
tions or interpersonal deficits), relating symptoms to
the problem area, and exploring alternative ways of
being in relationships with others. Psychotherapeutic
strategies used by the therapist include: seeking infor-
mation, exploring parallels in other relationships,
reviewing relationship and communication patterns,
signaling what is significant, providing support, ex-
ploring affect, reviewing options, problem-solving,
challenging maladaptive behaviors, and encouraging
adaptive changes [68]. Generally, IPT consists of 12 to
20 weekly sessions lasting 45 to 60 min that may be pro-
vided by psychiatrists and a range of non-medical health
professionals, including nurses [68-70].
Since its inception, IPT has been modified for different
age groups (that is, adolescents to elderly) [71,72], types
of mood disorders (that is, major depression, dysthymia,
bipolar disorder) [69], and non-mood disorders (that is,
bulimia, drug abuse, borderline personality disorder, so-
cial phobia, somatization, medically ill patients) [58]. It
has also been used in a group format. Evidence from
randomized controlled trials suggests that IPT is a rea-
sonable alternative or adjunct to antidepressant medica-
tion as an acute, continuation, and/or maintenance
treatment for patients with major depression [39]. In re-
lation to the perinatal period, eight studies haveevaluated the effectiveness of IPT for the treatment of
antenatal depression and PPD.
In a US pilot study, 12 depressed pregnant
women were offered eight weekly sessions of brief
IPT followed by monthly maintenance sessions up
to 24 weeks postpartum [73]. Nine participants
completed the study with post-treatment data show-
ing significant improvements in maternal mood,
anxiety, and social functions. In another US pilot
study, 13 depressed pregnant women were offered
16 weekly sessions of IPT [74]. Depression ratings
decreased significantly throughout the treatment
program and of the 10 women available for the 12-
week post-treatment assessment, none reported de-
pressive symptomatology using an Edinburgh Postna-
tal Depression Scale (EPDS) score >12. Building
upon this pilot work, a 16-week randomized con-
trolled trial was conducted with 50 low-income,
Hispanic pregnant women who met DSM-IV criteria
for depression; the mothers were randomly assigned
to receive either IPT (n = 25) or a didactic parenting
education program (n = 25) [75]. Thirty-eight (76 %)
women were included in the data analysis.
Depressed mood was measured with several instru-
ments including the EPDS. The IPT group showed
significant improvement compared to the parenting
education control program on all measures of mood
at post-treatment. Recovery criteria were met in
60 % of the women treated with IPT. These studies
suggest IPT may be a promising intervention for
antenatal depression.
IPT has also been evaluated for depression postnatally.
In a single-group US study, six mothers with PPD were
provided with 12 weekly sessions of IPT; significant
improvements in mood were found post-treatment [76].
Advancing this preliminary work in a well-designed ran-
domized controlled trial, 120 postpartum women meeting
DSM-IV criteria for depression were recruited from the
community and randomly assigned to either 12 weeks of
IPT (n=60) or a control group (n= 60) [77]. Follow-up
data were collected via interview and self-report assess-
ments of depressive symptomatology every 4 weeks; 99
(83 %) of the 120 women completed the protocol. Mean
Hamilton Rating Scale for Depression (HRSD) scores of
the women receiving IPT declined from 19.4 to 8.3, com-
pared to just a 3-point decrease from 19.8 to 16.8 in the
control group. Similarly, mean Beck Depression Inventory
(BDI) scores of the women who received IPT declined
from 23.6 to 10.6 over 12 weeks, compared to the control
group decrease from 23.0 to 19.2. More women who
received IPT recovered from their depressive episode
based on HRSD scores≤ 6 (37.5 %) and BDI scores≤ 9
(43.8 %) compared with women in the control group
(13.7 % and 13.7 %, respectively). However the outcomes
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sample was very homogeneous (for example, primarily
Caucasian, well-educated, and married).
IPT has also been evaluated in a group modality. In a
single-group study, 17 Austrian mothers diagnosed with
depression participated in 12 weekly sessions of group-
based IPT [78]. Women also were provided with the
telephone numbers of other group members to obtain
additional support if needed. Mean score comparisons
revealed significant changes from baseline to post-treatment
for both the EPDS and HRSD. At post-treatment, 10 (59 %)
mothers demonstrated full remission (HRSD< 9), 5 (29 %)
established partial remission (score decrease >50 %), and 2
(12 %) showed no improvement. Follow-up assessments at
24 weeks post-treatment revealed a continued effect.
However study limitations include the small sample
size, absence of a control group, possible outcome
assessment bias, and unknown level of intervention
adherence. Furthermore, the possible effect of the co-
intervention, telephone-based peer support, cannot be
dismissed. Similar results were found in a small study
of 18 depressed Australian mothers who were offered
eight sessions of group-based IPT [79]. EPDS scores
decreased pre- to post-treatment and the effect was
maintained at the 12-week post-treatment follow-up.
Limitations included the use of antidepressant therapy
by 67 % of mothers and the lack of a control group.
In a quasi-experimental study that included 36 US
mothers diagnosed with depression, both mother-infant
therapy and IPT were found to be superior to a waiting-
list comparison group in reducing maternal depressive
symptoms [80].
The connection between interpersonal relationships
and psychological wellbeing is well established [81];
smaller social networks, fewer close relationships, and
lower perceived adequacy of social support have all been
linked to depressive symptomatology [81,82]. Joiner [83],
in discussing the etiology of depression, noted that re-
gardless of what other factors may be involved, the inter-
personal context greatly affects: (1) whether a person
becomes depressed, (2) the person’s subjective experi-
ence while depressed, and (3) the behavioral manifesta-
tions and resolution of the disorder. Based on a leading
conceptual framework advanced by Cohen and Wills
[84], there are several pathways through which interper-
sonal relationships can affect psychological wellbeing.
Members of a social network may exert a salutary influ-
ence on mental health by providing normative guidance
about health-relevant behaviors [85]. Integration in a so-
cial network may also directly produce positive psycho-
logical states, including a sense of purpose, belonging,
and recognition of self-worth [86]. These positive states,
in turn, may benefit mental health due to an increased
motivation for self-care, as well as the modulation of theneuroendocrine response to stress [86]. Being part of a
broader social structure (for example, involvement in so-
cial networks and immersion in close relationships)
enhances the likelihood of accessing various forms of
support, which in turn protects against distress [87].
Examples of such resources include access to health-
relevant information or receipt of informal healthcare
that could prevent a minor ailment from progressing
into a more serious psychiatric disorder [86].
Interpersonal relationships may also act on several
different points in the pathway between stressful events
and eventual mental illness. First, the perceived avail-
ability of social support in the face of a stressful event
may lead to a more benign appraisal of the situation,
thereby preventing a cascade of ensuing negative emo-
tional and behavioral responses [88]. Second, perceived
or received support may either reduce the negative
emotional reaction to a stressful event or dampen the
physiologic/behavioral response to stress. Importantly,
social support strategies to decrease depressive symp-
tomatology have been described in the intervention lit-
erature [89,90] and through other descriptive studies
[86,91].
Traditionally, IPT has been provided individually in a
clinic setting or in a group modality. However, groups
are poorly attended by new mothers [44], especially
those who are feeling depressed; additional barriers to
PPD treatment include stigma, lack of accessible treat-
ment, time constraints, geographic barriers, and
demands of child care [44]. Attrition rates in PPD clinic
or group-based IPT trials are high, ranging from 20 % to
35 % [77,78]. An alternative to face-to-face healthcare
contact is through telemedicine which has many advan-
tages for diverse health problems [92-99] and has led
some researchers to suggest that the telephone is per-
haps one of the most under-utilized resources in health-
care [99]. Telephone-based interventions are not only
flexible, private, and non-stigmatizing, but they also re-
duce differences related to socio-economic status and
traditional healthcare barriers such as accessibility due
to transportation or geography [98,100]. While in the
last decade advances in technology, such as the
utilization of email and the internet, have enhanced the
range of options available for ‘home’ support, the tele-
phone remains the most accessible to the majority of
individuals [92].
Importantly, preliminary results suggest that IPT may
be effectively provided via telephone. In a 12-week pilot
randomized controlled trial to test the feasibility and ef-
ficacy of IPT delivered over the telephone, 30 depressed
US women were randomized to receive either tele-
phone-based IPT or no treatment [101]. Patients were
interviewed at baseline and immediately post-treatment
by a blind, clinical evaluator. Women in the intervention
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significantly lower levels of depressive symptomatology
as measured by the HRSD and improved social function-
ing as measured using the Social Adjustment Scale.
These findings support the feasibility of providing IPT
via telephone and that it may be an effective treatment
for depression. Furthermore, 83 % of women were favor-
able toward the use of the telephone, 83 % saw the tele-
phone as facilitating treatment, and 75 % wanted to
continue their treatment via telephone. In relation to the
treatment of PPD via telephone, only one small study
has been published. In a US pilot test, 20 depressed
mothers were provided with 10 weeks of ‘telecare’ admi-
nistered by a nurse and consisting of modified cognitive
behavioral therapy, relaxation techniques, and problem-
solving strategies [102]. The BDI was administered pre-
and post-treatment with scores significantly lower
following treatment. Several other telephone-based
interventions have been successfully used with new
mothers [99], including Dennis’ Breastfeeding Peer
Support Trial [103]. These studies are examples that
suggest telephone-based interventions can positively in-
fluence maternal health outcomes including mood.
Relevant systematic reviews
Five Cochrane systematic reviews have been completed
related to PPD. Dennis evaluated the effect of psycho-
social and psychological interventions for the prevention
of PPD and found interventions may be more effective if
they were individually based, initiated postnatally, and
targeted mothers identified as ‘high-risk’ [104,105].
Dennis and Ross [106] evaluated the role of estrogen
and progestogen in the prevention and treatment of
PPD. Of the two included trials, progestogen was asso-
ciated with an increased risk of PPD, while estrogen ther-
apy had a modest value in the treatment of severe PPD.
Hoffbrand [107] evaluated the effectiveness of different
antidepressant medications, including comparisons to
other forms of PPD treatment. The only included trial
suggested that fluoxetine was just as effective as a course
of cognitive-behavioral counseling in the short-term.
However, > 50 % of eligible mothers refused participation
in the trial, primarily due to their reluctance to take anti-
depressant medication. Barlow [108] evaluated the effect
of group-based parenting programs on improving mater-
nal psychosocial health including depression; the findings
from the 23 trials suggested diverse parenting programs
are effective in the short term. While the mean group
drop-out rate was 28 %, several trials reported rates> 40
%; detailed analyses suggest mothers who were less edu-
cated, lower income, or an ethnic minority were more
likely to withdraw. Dennis and Hodnett [109] conducted a
systematic review of the effect of psychosocial and psycho-
logical interventions for the treatment of PPD. No studieshave been found evaluating the effect of telephone-based
IPT for PPD by any health professional.
Research questions
Primary research question
What is the effect of telephone-based IPT by trained
nurses on PPD at 12 weeks post-randomization (that is
immediately post-treatment for mothers in the interven-
tion group)?
Secondary research questions
What is the effect of telephone-based IPT by trained
nurses on: (1) PPD at 24 and 36 weeks post-
randomization (that is 12 and 24 weeks post-treatment
for mothers in the intervention group; (2) depressive
symptomatology at 12, 24, and 36 weeks post-
randomization; (3) anxiety at 12, 24 and 36 weeks post-
randomization; (4) couple relationship quality and ad-
justment at 12, 24, and 36 weeks post-randomization;
(5) couple attachment at 12, 24, and 36 weeks post-
randomization; and (6) health service utilization from
randomization to 36 weeks post-randomization?
Other research questions
Other research questions are: (1) what are the cost
implications of IPT versus usual care from a societal per-
spective; (2) what are mothers’ evaluations of their IPT
experience; (3) what are nurses’ evaluations of their ex-
perience in learning and providing IPT; and (4) what are




The primary outcome for this trial is PPD, as diagnosed
by the Structured Clinical Interview for DSM-IV
(SCID-I), administered at 12 weeks post-randomisation




Standard postpartum care as provided to all mothers, in-
cluding community PPD services.
Treatment group
Standard postpartum care as provided to all mothers in
addition to 12 weekly sessions of telephone-based IPT.
Randomization procedure
Randomization is centrally controlled using a web-based
randomization service, with stratification based on self-
reported history of depression and province. This
randomization service was successfully used by Dennis
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tion is planned, because postpartum care is based on
practice standards set by a province’s Ministry of Health.
As such, ‘standard postpartum care’ will be very different
for each province.Outcome measures
Primary outcome
Postpartum depression The primary outcome for this
trial is PPD, as diagnosed by the Structured Clinical
Interview for DSM-IV (SCID-I) [111] administered at
12 weeks post-randomization (Table 1). The SCID-I is a
semi-structured interview that includes an introductory
overview followed by nine modules, seven of which rep-
resent the major DSM diagnostic classes. Because of its
modular construction, the SCID-I can be adapted for
use in studies in which particular diagnoses (for ex-
ample, depression only) are of interest. As such, for this
trial, the Current Major Depressive Episode (MDE) sec-
tion of Module A will be used to indicate the presence
of a major depressive episode and the Melancholic Fea-
tures, Atypical Features, and Current Manic Episode
sections of Module A will be used to further evaluate
the severity of a potential participant’s mood episode(s)
and the impact of these subcategories on a participant’s
response to the IPT intervention.
There are more than 500 reports of published studies
using the SCID-I as a diagnostic instrument and the reli-
ability and validity has been extensively reported inTable 1 Timing of measurements
Time Outcome measures
Baseline (1) SCID-I, (2) EPDS, (3) STAI-State Anxiety Inventory,
(4) Dyadic Adjustment Scale, (5) Experiences in




(1) SCID-I, (2) EPDS, (3) STAI-State Anxiety Inventory,
(4) Dyadic Adjustment Scale, (5) Experiences in
Close Relationships-Revised, (6) Maternal Health
Service Utilization and Cost of Care Questionnaire,
(7) Maternal Satisfaction with IPT Questionnaire (to
be completed by mothers in the intervention
group), and (8) IPT Activity Log (to be submitted to
the Data Coordinating Center by the IPT nurse)
24 weeks post-
randomization
(1) SCID-I, (2) EPDS, (3) STAI-State Anxiety Inventory,
(4) Dyadic Adjustment Scale, (5) Experiences in
Close Relationships-Revised, and (6) Maternal




(1) SCID-I, (2) EPDS, (3) STAI-State Anxiety Inventory,
(4) Dyadic Adjustment Scale, (5) Experiences in
Close Relationships-Revised, and (6) Maternal
Health Service Utilization and Cost of Care
Questionnaire
Continuous Nurse IPT Experience Questionnaire (to be
completed either at the end of the trial or when
an IPT nurse discontinues trial participation)diverse studies and samples [112]. In particular, research
evaluating the SCID-I has found the measure to yield
highly reliable diagnoses for most disorders [112,113],
with inter-rater reliability often exceeding 81 % for diag-
noses such as major depression [114]. The SCID-I has
also been effectively used with postpartum women to as-
sess depression [115-120]. The SCID training materials,
for both clinicians and research personnel, include a
user’s guide and eight videotapes. At the UCLA Research
Center for Major Mental Illnesses, a training and quality
assurance program was used to evaluate SCID inter-
rater reliability and diagnostic accuracy. Both clinically
experienced interviewers and recently trained neophyte
interviewers were able to achieve and maintain high
levels of inter-rater reliability, diagnostic accuracy, and
interviewer skill; at the first quality assurance check after
training, there were no significant differences between
experienced and neophyte interviewers in inter-rater re-
liability or diagnostic accuracy [121].
The SCID-I is also administered at 24 and 36 weeks
post-randomization, as a secondary outcome. While
some attrition of the sample is expected by this time, the
additional information will provide important evidence
of longer-term effects of the IPT intervention.
Secondary outcomes
Depressive symptomatology This outcome is measured
using the Edinburgh Postnatal Depression Scale (EPDS)
[122], a 10-item self-report instrument. Items are rated
on a 4-point scale to produce a summative score ranging
from 0 to 30, with higher scores indicating lower mater-
nal mood. This instrument does not diagnosis PPD but
rather it is the most frequently used instrument to assess
for postpartum depressive symptomatology [16]. Of the
30 PPD treatment studies found in the extant literature
[43,123], 83 % (n= 25) used a self-report measure to
evaluate whether the intervention was effective. Of these
25 studies, 18 (72 %) incorporated the EPDS. Created to
counter the limitations of other well-established depres-
sion scales, it has been validated by standardized psychi-
atric interviews with large samples and has well-
documented reliability and validity in over 11 languages
[14]. The published recommended EPDS cutoff score of
> 12 [122] is used to examine depressive symptomatol-
ogy at 12, 24, and 36 weeks post-randomization.
Anxiety This outcome is measured using the Spielber-
ger State-Anxiety Inventory (STAI-State) [124], a 20-
item self-report instrument developed to assess levels of
relatively transient situation-related (state) anxiety. Items
are rated on a 4-point Likert-type scale to produce a
summative score ranging from 20 to 80 with higher
scores indicating higher levels of anxiety. The STAI-State
has been used widely in pregnancy and postpartum
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pressive symptomatology in new mothers [16].
Attachment This outcome is measured using a revised
version of Brennan, Clark, and Shaver’s Experiences in
Close Relationships (ECR) questionnaire, the ECR-
Revised (ECR-R) [125]. The ECR-R yields scores on two-
dimensional subscales: attachment-related anxiety (that
is fear of rejection and abandonment; items 1 to 18) and
attachment-related avoidance (that is discomfort with
closeness and discomfort with depending on others;
items 19 to 36). Each item is rated on a 7-point scale
that ranges from 1 (strongly disagree) to 7 (strongly
agree). For the present trial, only those who report living
with a spouse or partner in an intimate relationship
complete this questionnaire.
Relationship quality and adjustment This outcome is
measured using the Dyadic Adjustment Scale (DAS)
[126]. The DAS is a comprehensive, 32-item scale fre-
quently used to measure adjustment in couple relation-
ships, an aspect of relationship quality. Items are rated
on Likert-type scales, with total DAS scores ranging
from 0 to 150. A total DAS score may be derived by
summing across the four subscales, each of which vary
in length: dyadic consensus (items 1–3, 5, 7–15; score
range 0 to 50), dyadic satisfaction (items 16–23, 31, 32;
score range 0 to 24), dyadic cohesion (items 24–28;
score range 0 to 65), and dyadic affectional expression
(items 4, 6, 29, 30; score range 0 to 12) [126]. The DAS
has demonstrated good psychometric properties with di-
verse populations and is commonly used in PPD studies
[126,127]. Increased relationship quality and adjustment
has been associated with decreased depressive symptom-
atology in postpartum women [127]. For this trial, only
those who report living with a spouse or partner in an
intimate relationship complete the DAS.
Health service utilization This outcome is measured
using a slightly modified version of the Health Service
Utilization and Cost of Care Questionnaire [128], a self-
report instrument developed and used by researchers at
McMaster University’s Health and Social Service
Utilization Research Unit. Previous research by Dennis
[129] suggests that mothers with depressive symptom-
atology in the early postpartum period used significantly
more health services than mothers with no depressive
symptomatology.
Other outcomes
Maternal evaluation of IPT This outcome is measured
using the Maternal Satisfaction with IPT Questionnaire.
Based on (1) Dennis’ previous maternal satisfaction
questionnaires for the Breastfeeding [103] and PPDprevention trials [110,130], (2) the Client Satisfaction
Questionnaire [131], and (3) the Patient Satisfaction
Questionnaire [132], this outcome is assessed at 12 weeks
post-randomization by the trial coordinator (who is not
collecting any primary or secondary outcome data).
Nurse evaluation of IPT training and intervention
This outcome, assessed via telephone at the end of the
trial, is measured using the Nurse IPT Experience Ques-
tionnaire. Based on similar content areas used in Dennis’
previous trials [103], questions are related to (1) IPT
training, (2) supervision, (3) provision of IPT, and (4)
personal effects.
Nurse IPT activities All intervention activities (for ex-
ample, telephone discussions, left messages, missed ses-
sions) are documented by the IPT nurses using the IPT
Activity Log. IPT nurses are requested to return the ac-
tivity log for a mother immediately post-treatment. This
activity log is similar to ones used in Dennis’ previous




Two hundred and forty mothers >2 weeks and
<24 weeks postpartum.
Justification for sample size
PPD psychosocial and psychological treatment trials
have reported control group spontaneous recovery rates
(EPDS< 13) ranging from 25 % to 40 % [130,133-136].
The difference in recovery rates between groups in these
trials ranged from 27 % to 55 %, with 66 % to 85 % of
mothers in the intervention group classified as non-
depressed at the primary outcome time period. Among
perinatal IPT trials (including both antenatal depression
and PPD) where participant inclusion criteria included a
clinical diagnosis of depression, reported control group
spontaneous recovery rates (for example, HRDS< 7, BDI
< 10) ranged from 15 % to 18.3 % [75,77]. The difference
in recovery rates between groups in these trials ranged
from 16.7 % to 44.6 %, with 32 % to 60 % of mothers in
the intervention group classified as non-depressed at the
primary outcome time period. These results should be
interpreted with caution, due to the different methods of
measuring depressive symptomatology and small sample
sizes. In the most rigorous IPT trial for PPD (n= 120),
38.3 % of mothers in the IPT group and 18.3 % of
mothers in the control group were classified as non-
depressed immediately post-treatment (that is 12 weeks
post-randomization), a 20 % difference [77].
Given that (1) all the preceding studies used self-
report measure to assess recovery (for example, no
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score) instead of a diagnostic interview such as the
SCID, and (2) the proposed trial’s sample will be het-
erogeneous and include rural and urban mothers
from diverse provinces, for the purpose of calculating
the sample size, we have made the conservative as-
sumption that 30 % of mothers in the control group
will spontaneously recover and will not have major
depression at the 12 week post-randomization assess-
ment (70 % will remain clinically depressed) (Table 2).
The sample size is based on the ability to detect a
moderate decrease of 20 percentage points to a rate
of 50 % among mothers in the intervention group.
Our partners in the participating public health depart-
ments agree that a 20 % absolute decrease in the
number of mothers with depression post-treatment is
the minimum effect that would be considered clinic-
ally meaningful, warranting the time and effort to de-
velop and implement an IPT program. A two-tailed α
error of 0.05 was chosen, as there is insufficient em-
pirical evidence of either risk or benefit associated
with the proposed telephone-based IPT intervention.
Thus, with 80 % power, a two-tailed α error of 0.05,
and using a test of two independent proportions to
find a 20 % reduction in the number of mothers with
depression at 12 weeks post-randomization (immedi-
ately post-treatment for mothers in the intervention
group), a sample size of 188 (94 per group) is
required; we plan to enroll 240 to allow for up to
20 % loss to follow-up. This sample size also provides
power to detect a 20 % absolute reduction in other
secondary outcomes, such as anxiety.
Inclusion criteria
Inclusion criteria are: (1) live birth; (2) mother 2 to
24 weeks postpartum; (3) infant discharged from hos-
pital and at home with mother; (4) clinical diagnosis of
major depression using the SCID-I; and (5) understands
spoken English. Due to the nature of the intervention, it
is not feasible to recruit mothers unable to speak
English.
Exclusion criteria
Exclusion criteria are: (1) current use of antidepressant
or antipsychotic medication; (2) currently receiving any









5 45 96trained professional; (3) active suicidal or self-harm
thoughts; (4) current or past manic depression or bipolar
diagnosis; and (5) chronic depression (episode length
> 2.0 years). These exclusion criteria are consistent with
other IPT trials [71,72,77].
Trial process
Referrals
Referrals for the trial come from a variety of sources in-
cluding public health departments, mental health units,
and private practice clinics.
Public health
Currently, 24 public health departments across Canada
(Ontario, Manitoba, Saskatchewan, and British
Columbia) are assisting with recruitment for this trial. In
Canada, public health departments receive notification
of women who have given birth in their health region.
As part of standard practice, each mother receives a tele-
phone call or home visit from a public health nurse
within the first few weeks postpartum following hospital
discharge. During these interactions, public health
nurses often administer the EPDS to assess maternal
mood. A brief description is provided to mothers who
are identified as experiencing depressive symptomatol-
ogy (EPDS> 12) after the first 2 weeks postpartum (in
order to avoid false-positives that are ‘maternity blues’).
If verbal consent is obtained, the potentially eligible
mother’s contact information is sent to the trial
coordinator.
Other health professionals
In addition to referrals from public health departments,
health professionals in public or private practice across
Canada may also refer potentially eligible mothers.
Self-referrals
Women who are between 2 and 24 weeks postpartum
and self-identify as feeling down or depressed may also
self-refer to the trial.
All referred mothers are contacted by the trial coord-
inator and provided a detailed explanation of the study.
If the mother expresses interest in participating in the
trial, she is further assessed for eligibility. Eligible
women are asked to provide verbal consent to partici-
pate in the study; if she consents, baseline information is
collected by the trial coordinator. Using a web-based,
centrally controlled randomization service, the mother is
randomized to either the control (standard postpartum
care) or intervention group (standard postpartum care
plus 12 telephone-IPT sessions), with stratification based
on province and self-reported history of depression. Fol-
lowing randomization, participants are immediately
informed of their study group assignment.
Administer EPDS and (further) 
assess eligibility
Ask for consent 
No to consent or 
not eligible
Yes to consent and 
eligible






















Mother refers herself to trial 
Provide study explanation
Consent to refer as needed
Postpartum contact by PHN or 
other healthcare clinician
Figure 1 Trial Process.
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Two copies of the study explanation and participant
consent form are mailed to each participant. A postage-
paid, addressed envelope is included in the mailed pack-
age so that one copy of the signed consent form is
returned to the trial coordinator and the other copy is
retained by the participant for her own records. These
informed consent procedures have been used effectively
by Dennis in previous trials [110,130].
With detailed informed consent procedures, it is
expected that mothers will accept their group alloca-
tion following randomization. While most healthprofessionals caring for participants and research
nurses will be blinded, mothers cannot be. However,
a formal telephone-based IPT PPD program does not
already exist in the participating health regions,
thereby ensuring no mother in the control group will
receive the intervention. There will be no interference
with usual medical/nursing care, which for some
mothers may include antidepressant medication and/
or psychotherapy. Very few mothers will have avail-
able and receive psychotherapy. As such, the actual
number of trial participants in the control group who
will receive psychotherapy will be very small; data
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trial will be collected during the health service
utilization assessment. Information about interven-
tions to treat PPD will be obtained from the partici-
pants and considered in the data analyses.
Treatment
Mothers allocated to the treatment group are contacted
by the IPT nurse within 72 h of trial randomization and
then weekly thereafter for 12 sessions.
Post-randomization data
To assess compliance to IPT, all intervention activities (for
example telephone discussions, left messages, missed ses-
sions) are documented by the IPT nurses using the IPTAc-
tivity Log. IPT nurses are requested to return the activity
log for a mother immediately post-treatment.
Follow-up
Research nurses blinded to participant group allocation
telephone study participants at 12, 24, and 36 weeks
post-randomization/post-treatment to determine trial
outcomes. PPD at 12 week post-randomization was
chosen as the primary outcome because (1) we desire to
provide comparable results to other perinatal IPT trials
[73-80], and (2) the likelihood of losses to follow-up in-
crease over time. So as to (1) address criticisms of previ-
ous trials related to insufficient follow-up to determine
the longer-term effects of IPT and (2) present compar-
able results to other PPD treatment trials [137,138] in-
cluding IPT trials [77,78], participants are contacted
again at 24 and 36 weeks post-randomization and
assessed for PPD and other outcomes (Figure 1).
All outcome data are administered over the telephone
and entered into a Microsoft Access database with built-
in logic and range checks to allow for immediate correc-
tion of errors and insertion of missing data.
Ethical approving body
This research protocol has been granted full ethical ap-
proval by the University of Toronto Health Sciences Re-
search Ethics Board.
Recruitment rate
The participant recruitment rate for this trial is founded
on three factors: (1) the ability of public health nurses
and other health professionals to identify and refer
mothers with depressive symptomatology (EPDS> 12),
(2) the number of referred mothers diagnosed with
major depression (based on SCID interview), and (3)
participant acceptance of the trial. Based on the health
regions’ birth rates, the assumption that approximately
13 % of mothers will experience PPD [15], and that less
than 50 % of mothers seek treatment for PPD [44], weconservatively estimate that 20 % of depressed mothers
will be detected by public health nurses and other health
professionals each year. In one IPT trial that initially
identified mothers with a self-report measure (for ex-
ample EPDS> 12) before applying a clinical diagnosis
(for example SCID), only 65 % of women with depressive
symptomatology were diagnosed with major depression
[78]. In another IPT trial, 64 % of patients identified
with depressive symptomatology (for example CES-D)
were diagnosed with major depression [139]. Research
has demonstrated high maternal acceptance to complet-
ing the EPDS [130] and both of Dennis’ breastfeeding
[103] and PPD prevention trials [110,130] had good ac-
ceptance rates (> 66 %) to postpartum telephone-based
interventions. Furthermore, in a review of maternal
treatment preferences completed by Dennis, depressed
mothers clearly indicated that they preferred ‘talking
therapies’ [44]. For PPD IPT trials that were either clinic
or group-based, acceptance rates of eligible mothers ran-
ged from 51 % [77] to 68 % [79]. As such, we expect to
recruit our sample size of 240 mothers with major de-
pression in 2.5 years based on: (1) a public health de-
partment 20 % identification rate of mothers with EPDS
scores> 12, (2) a conservative 50 % clinical diagnosis of
major depression rate, (3) a 50 % maternal acceptance




Mothers allocated to the treatment group receive 12
weekly IPT sessions, each session 50 to 60 min in dur-
ation and delivered over the telephone by a trained IPT
nurse who receives weekly supervision by an IPT trainer
(PR and SG). Within 72 h, the IPT nurse will either ad-
minister session 1 (if possible) or at least make an initial
call to the participant to schedule session 1 (to occur
within the week following enrolment). The scheduling of
IPT sessions are based on mutual availability between
the mother and IPT nurse. IPT is administered accord-
ing to the standardized manual by Stuart and Robertson
[56,140], with some modifications to accommodate the
postpartum context of depression. These modifications
are based on previous IPT trials for PPD [141].
As conducted in standard IPT clinical practice, a mi-
nority of trial participants identified as either in acute
crisis at the end of treatment, or who are progressing
however remain significantly symptomatic, thus would
benefit from extending the course, may be offered up to
four additional IPT sessions (that is, conduct 12 or a
maximum of 16 sessions per trial participant, as appro-
priate). A full course of therapy must be completed
within 16 weeks to account for any additional sessions
and/or occasional scheduling conflicts or difficulties.
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cing the depression in an interpersonal context, review-
ing the mother’s current and past interpersonal
relationships, and relating problematic aspects of their
relationships to the mother’s current depression. The
IPT nurse and mother will collaboratively identify the
problem area(s) most related to the episode and set
treatment goals. During the intermediate sessions (4 to
9), the nurse will focus on the interpersonal difficulties
identified by the mother, and utilize the IPT therapeutic
guidelines to work through these focal problems. Based
on previous IPT trials [77,141], common postpartum
IPT problem areas include conflict with partner or
extended family (interpersonal disputes), loss of social/
work relationships (role transition), and losses unassoci-
ated with the birth, such as the death of a significant
other (grief ). In the final sessions (10 to 12), the nurse
will reinforce the mother’s progress and efforts, her
sense of competence in overcoming depression, consoli-
date her gains, discuss feelings or worries about con-
cluding therapy, and work with the mother to develop
plans should the depression recur. All sessions are
audio-taped for supervision and monitoring purposes.
IPT training
Recruited nurses undergo extensive IPT training as lead
by highly skilled and experienced IPT supervisors, Ravitz
and Grigoriadis (also psychiatrist co-investigators) com-
prised didactic learning and supervised clinical practice.
Previous studies have demonstrated that nurses can be
effectively trained to provide IPT [68-70]. Prior to trial
initiation, IPT nurses read and become familiar with the
Interpersonal Psychotherapy manual (by Stuart and
Robertson) and the postpartum modifications based on
previous PPD IPT trials [141]. Each IPT nurse attends a
didactic workshop with videotape presentations (mini-
mum 5 h duration), meeting the standard for training of
IPT therapists.
In addition to attending a workshop and reading about
IPT, study nurses must successfully complete two super-
vised IPT clinical cases of 12 sessions each with patient
volunteers who have been diagnosed by referring psy-
chiatrists with PPD. The first case is done in person, and
the second case is conducted by telephone following one
initial face-to-face meeting with the nurse. All sessions
are audio-recorded and reviewed in full by the supervi-
sors who provide weekly supervision and feedback on
the clinically applied principles and therapeutic techni-
ques of IPT. An IPT nurse is considered ‘fully trained’
and prepared to administer the intervention to enrolled
trial participants when she demonstrates a high degree
of therapeutic competence and adherence (as monitored
by IPT supervisors) and successfully completes IPT ad-
ministration to the two test cases.IPT supervision
While some researchers suggest that IPT therapists who
perform well on their first supervised case do not re-
quire further intensive supervision [142], to ensure on-
going treatment fidelity, all fully trained and trainee IPT
nurses are required to participate in weekly group super-
vision meetings. IPT nurses are also able to contact
intervention supervisors as necessary to address immedi-
ate concerns.
IPT rating
Audio-recorded IPT sessions are randomly reviewed by
an independent and IPT-trained rater to document
treatment fidelity using the IPT Adherence Checklist.
Adherence raters are trained to achieve> 90 % agree-
ment with one of the IPT expert trainers.
Compliance
It is expected that 80 % of the intervention group will
receive IPT due to the specific inclusion/exclusion cri-
teria, informed consent procedures, and intervention
compliance procedures. Some of the participants will
drop out because of their preference for in-person ther-
apy, scheduling difficulties, unsuccessful contact post-
randomization or due to crises that can in some cases
require contact with child protection service agencies,
public health and/or their family physicians. In this trial,
treatment compliance means the completion of at least
10 IPT sessions. Monitoring compliance of the interven-
tion are three-fold: (1) IPT nurses’ completion of IPT
Activity Logs for each participant, (2) supervision of the
IPT intervention as provided by Ravitz and Grigoriadis,
and (3) mothers’ evaluations of their IPT experiences.
Loss to follow-up
Maternal questionnaires were designed to require low
levels of literacy and relatively little time to complete;
they have been used previously with postpartum
mothers and examined for clarity, comprehension, and
ease of use. In particular, all measures (except the DAS
and ECR-R) were used as outcome measures in Dennis’
PPD prevention trial with no difficulty. Attrition is a sig-
nificant threat to both internal and external validity in
intervention and longitudinal studies, as the average re-
tention rate of 6-month to 2-year follow-up studies has
been estimated at 62 % [143]. The following proactive
telephone strategies [144] are employed to encourage
high retention rates. Each questionnaire contains a con-
tact form for the IPT nurse to record the date, time of
call, status of call (for example busy, call back, no answer,
and so on), and comments. Participants are telephoned
during their stated’best time to contact’ period, surveys
are cycled up to three times per day, and if possible, mes-
sages are left. Directory assistance is telephoned for all
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minimum response rate of 90 %. Additional strategies to
ensure a low attrition rate, based on a Cochrane review
[145] and other research [146], are as follows: (1) obtaining
a secondary contact number (such as the participant’s
mother) from each participant at recruitment, (2) conduct-
ing telephone reminder calls of impending interviews, and
(3) providing a small token of appreciation provided to all
mothers who complete the 36-week post-randomization
interview. Similar strategies were used in Dennis’ PPD pre-
vention trial [110] with good results (retention rate = 87 %
at 12 week assessment and 85 % at 24 week assessment).
Statistical analysis plan
Primary analysis
Data will be analyzed using SAS software and an intent-
to-treat approach will be used. Every effort will be made
to collect follow-up data from all participants. We will
not impute a score for missing primary outcome data.
A two-sided significance level of 0.05 will be used for
the primary outcome; a significance level of 0.01 (two-
sided) will be used for secondary and other outcomes to
account for multiple comparisons. The demographic
and other baseline variables will be compared between
study groups using descriptive statistics (means, stand-
ard deviations, proportions). For the primary analysis, a
two sample two-sided test of proportions will be used
to compare the difference in the incidence of PPD
(major depression using the SCID) at 12 weeks post-
randomization between the intervention and control
groups. For secondary analyses, the statistical method
to compare groups will depend on the distribution of
the outcome variable in question. For binary variables
(for example EPDS score> 12), a contingency table chi-
square for a 2 × 2 table will be calculated and presented
together with estimates for the relative risk, relative risk
reduction, absolute risk reduction, and the number
needed to treat. The corresponding 95 % confidence
intervals for each estimated parameter will also be pro-
vided. Covariate variable adjustment will be achieved
using logistic regression. For ordered categorical vari-
ables, a chi-square for trend will be calculated. Relative
risks for each category versus a base category will be
presented. Continuous variables with repeated meas-
urement (such as anxiety) will be first analyzed using a
single, repeated measures MANOVA consisting of
group and time factors to test for the study’s overall
intervention, time, or interaction effect. Following the
detection of a significant effect, separate repeated mea-
sures 2-factor analyses of variance (RANOVA) with ap-
propriate contrasts will show the nature of the effect
within each outcome variable. Covariate variable ad-
justment will be achieved using analysis of covariance
and linear regression. Finally, the relationship betweenthe number of IPT sessions on PPD, and other study
outcomes will be assessed to determine an effective
dose response.
Economic evaluation
The proposed intervention may have economic implica-
tions through two mechanisms. First, there may be dif-
ferential personnel and administrative costs related to
the IPT program itself. Second, pilot data suggest that
the intervention may lead to decreased use of healthcare
resources [130]. The objective of the economic analysis
will be to estimate the cost-effectiveness of the addition
of telephone-based IPT compared to standard postpar-
tum care of mothers with PPD. In order to facilitate
comparison with other healthcare programs, the analysis
will take a societal perspective, in which consideration
will be given to all costs regardless of the parties to
whom they accrue. Thus, direct medical costs will be
supplemented by data on volunteer labor costs, medical
and non-medical costs borne by the mother herself or
her family, and mother or family time absent from work.
Cost data will also be presented in a disaggregated for-
mat to improve the generalizability of the results to par-
ties having other perspectives, such as the provincial
ministry of health or community organizations.
Comparators and time horizon
The alternatives in the trial are telephone IPT vs. stand-
ard postpartum care of mothers with PPD. Given that
IPT in this context is adjunctive, the economic analysis
will retain a high degree of external validity. The eco-
nomic component of the study will measure costs from
randomization to 36 weeks post-randomization. We
recognize that the resource implications of the trial
intervention will probably extend beyond that point. As
the incidence of affective symptoms gradually decreases,
however, the longer-term cost differences between pro-
grams are also likely to decrease. Moreover, the costs of
implementing the intervention itself will be fully cap-
tured. The measured cost-effectiveness will therefore be
a conservative estimate. Decision analytic modeling of
longer-term outcomes beyond 36 weeks will be under-
taken in secondary analyses if there are still differences
between groups in resource utilization and costs at the
end of trial data collection.
Analytic technique
Results will be approached using incremental cost-
effectiveness analysis, in which the additional costs
and effects for the IPT will be compared to the
costs and effects of standard community postpartum
care for mothers with PPD. All analyses will be per-
formed on an intention-to-treat basis.
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We anticipate that resource use will consist of the fol-
lowing factors: (1) direct medical costs, including (a) fees
for healthcare professionals (b) hospital care, (c) drug
prescriptions (anti-depressant medication); (2) direct
non-medical costs, including (a) travel costs incurred by
patients to obtain care, (b) child care expenses; (3) prod-
uctivity losses due to patient and family work absence;
and (4) cost to administer the IPT intervention including
(a) recruiting and training nurses, (b) nurses’ time for
providing IPT, and (c) IPT supervision.
Resource use will be ascertained through activity logs
completed by the IPT nurses. For the use of professional
healthcare services, participants will complete a slightly
modified version of the self-report Health Service
Utilization and Costs of Care Questionnaire [128]. The
latter questionnaire also includes items for direct non-
medical costs and work absence.Valuation of unit costs
Physician fees will be derived from local provincial fee
schedules [147] and average hourly wages for registered
nurses will be applied. Price weights for hospitalization
episodes will be obtained using aggregate data from
standardized hospital cost accounting systems in British
Columbia and Alberta and from the Ontario Case Cost
Project of the Ministry of Health Joint Policy and Plan-
ning Committee [148]. Total costs per patient will be
the summed products of quantities of resources used
multiplied by these unit prices. Given that the time hori-
zon for the measured outcomes included in the current
study protocol is short, discounting of costs and effects
will not be undertaken for the primary analysis.Determination of effects
Efficacy will be expressed as the recovery of PPD at
12 weeks post-randomization (immediately post-
treatment for mothers in the intervention group), as
dictated by the primary outcome of the trial. Second-
ary cost-effectiveness ratios consistent with the trial’s
secondary endpoints will also be reported. Given the
relatively standardized nature of the intervention and the
acute setting, compliance is anticipated to be good. Fur-
thermore, the study population is not very restrictive, with
the only excluded patients being those already receiving
pharmacological or psychotherapeutic intervention, those
with a current or past bipolar diagnosis, and/or those with
chronic depression or suicidal ideation, most of whom
would not avail themselves of the intervention outside of
the trial context. It is likely therefore that the economic
evaluation will have very good external validity; no adjust-
ments to approximate real-world effectiveness are
planned.Budgetary impact analysis
In addition to the preceding efficiency analysis, the
budgetary impact at the participating health regions will
be explored. In this analysis, the total personnel costs
for each of the health units will be compared, assuming
that health units either persist with standard postpartum
care for mother with PPD or alternatively adopt the tele-
phone-based IPT program. This analysis will assume
that the care of new mothers with PPD had costs and
outcomes of either the intervention or control group.
The analysis will be repeated under several assumptions
regarding the size of the program, the percentage of
depressed mothers identified, and the percent of a nurs-
ing full-time equivalent required to provide and main-
tain the IPT program.
Uncertainty and statistical issues
Uncertainty will be assessed through sensitivity ana-
lysis for non-stochastic inputs such as choice of price
weights. For stochastic variables including efficacy
and costs, a non-parametric bootstrap method will be
used to generate joint confidence intervals for the
cost-effectiveness ratio. This technique involves
resampling, with replacement, of the observed distri-
bution of costs and effects, to establish an empirical
distribution of cost-effectiveness ratios, from which
confidence intervals can be constructed. Sample size
will be determined by statistical consideration for the
detection of efficacy in the clinical trial. In the ab-
sence of information regarding the dependence of
costs and effects, it is problematic to determine
power for comparisons of cost-effectiveness ratios a
priori. The economic evaluation will therefore take an es-
timation, rather than hypothesis testing, approach to the
construction of incremental cost-effectiveness ratios.
Cost-effectiveness ratios and 95 % confidence intervals
will be estimated using non-parametric bootstrapping
[149]. The frequency with which these intervals overlap
with cost-effectiveness thresholds of $0 to $300,000 per
PPD recovery will be reported using cost-effectiveness ac-
ceptability curves.
Exploratory analyses
Exploratory analyses will be performed using data col-
lected in the entire sample to explore relationships
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